David Einhorn
Greenlight Capital
David Einhorn Teva Pharma Industries Ltd ADR stake
total: 357
Greenlight Capital TEVA trades
- Total transactions:
- 8
- New positions:
- 1
- Added:
- 4
- Reduced:
- 3
- Held since:
- 2023 Q4
- Held for:
- 11 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, David Einhorn holds 2,886,059 Teva Pharma Industries Ltd ADR (TEVA) shares with a market value of roughly $97.78M accounting for 2.50% of the overall portfolio. To date, the estimated cost basis is nearly $16.44 for "buy" trades and estimated average "sell" price is $31.1. Greenlight Capital first purchased TEVA in 2023 Q4, initially acquiring 268,470 shares. Since the initial investment in Teva Pharma Industries Ltd ADR (TEVA), Greenlight Capital has made 7 more transactions.
When did David Einhorn buy Teva Pharma Industries Ltd ADR (TEVA)?
David Einhorn first invested in Teva Pharma Industries Ltd ADR (TEVA) in 2023 Q4 at the reported quarter-end price of $10.44 per share.
What's the cost basis of Greenlight Capital's TEVA stake?
The estimated cost basis for Teva Pharma Industries Ltd ADR (TEVA) stake is around $16.44 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $16.44
- Weighted AVG sell price:
- $31.10
David Einhorn's historical trades in Teva Pharma Industries Ltd ADR
8 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
2.50%
|
2,886,059
|
$33.88
|
$97,779,679
|
-0.85% (-24,670)
|
-0.03%
|
|
2026 Q1
|
2.75%
|
2,910,729
|
$30.12
|
$87,671,158
|
-4.84% (-148,005)
|
-0.16%
|
|
2025 Q4
|
3.35%
|
3,058,734
|
$31.21
|
$95,463,088
|
-19.05% (-720,043)
|
-0.88%
|
|
2025 Q2
|
2.72%
|
3,778,777
|
$16.76
|
$63,332,302
|
+565.04% (+3,210,577)
|
+2.31%
|
|
2025 Q1
|
0.44%
|
568,200
|
$15.37
|
$8,733,234
|
+21.27% (+99,650)
|
+0.08%
|
|
2024 Q4
|
0.53%
|
468,550
|
$22.04
|
$10,326,842
|
+44.24% (+143,700)
|
+0.16%
|
|
2024 Q1
|
0.21%
|
324,850
|
$14.11
|
$4,583,634
|
+21.00% (+56,380)
|
+0.04%
|
|
2023 Q4
|
0.14%
|
268,470
|
$10.44
|
$2,802,826
|
new
|
+0.14%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.